Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

Science

Volumn 267, Issue 5197, 1995, Pages 518-522

  Chang, Mark W ^a   Barr, Eliav ^a   Seltzer, Jonathan ^a   Jiang, Yue Qin ^a   Nabel, Gary J ^b   Nabel, Elizabeth G ^b   Parmacek, Michael S ^a   Leiden, Jeffrey M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; RETINOBLASTOMA PROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CELL PROLIFERATION; CONTROLLED STUDY; FEMORAL ARTERY; GENE THERAPY; GENE TRANSFER; INTIMA; MUSCLE FIBER CULTURE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TUMOR SUPPRESSOR GENE; VASCULAR SMOOTH MUSCLE; VIRUS INFECTION;

ADENOVIRIDAE; ANGIOPLASTY, BALLOON; ANIMAL; BASE SEQUENCE; BLOOD; CAROTID ARTERIES; CELL DIVISION; DISEASE MODELS, ANIMAL; FEMORAL ARTERY; GENE THERAPY; GENES, RETINOBLASTOMA; GENETIC VECTORS; HUMAN; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; RETINOBLASTOMA PROTEIN; SUPPORT, U.S. GOV'T, P.H.S.; SWINE; VASCULAR DISEASES;

EID: 0028902753     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.7824950     Document Type: Article

References (0)